Brighton Jones’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Brighton Jones's EDIT Position: Q3 2026 in Review
Brighton Jones reduced its Editas Medicine (EDIT) stake by 32% in Q3 2026, selling an estimated $16.6K and leaving 12,085 shares worth $31.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1371.
Brighton Jones first reported a position in EDIT in Q2 2026 and has held it in 2 quarters since. The position peaked at $57.5K in Q2 2026. 181 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Brighton Jones held 12,085 shares of Editas Medicine worth $31.1K as of Q3 2026.
- Brighton Jones sold 5,666 Editas Medicine shares in Q3 2026, an estimated $16.6K.
- Editas Medicine made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1371 holding.
- Brighton Jones first reported a position in Editas Medicine in Q2 2026 and has held it in 2 quarters since.
- Brighton Jones's Editas Medicine position peaked at $57.5K in Q2 2026.
- 181 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.